PortViewPortView
Acer Therapeutics logo

Acer Therapeutics (ACER) Stock Analysis

NASDAQHealthcareBiotechnology

$0.66-17.95%
1-year price historyRange $0.57 – $4.15
52-week range$0.66
$0.55$4.56

What Acer Therapeutics does

Acer Therapeutics Inc. is a pharmaceutical company dedicated to acquiring, developing, and commercializing treatments for severe rare and life-threatening conditions. Its clinical-stage pipeline features four key candidates: EDSIVO, for vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mutation; ACER-001, a sodium phenylbutyrate formulation addressing inborn errors of metabolism such as urea cycle disorders and maple syrup urine disease; ACER-801 (osanetant), designed to manage induced Vasomotor Symptoms; and ACER-2820 (emetine), a host-directed therapy showing promise against various infectious diseases, including COVID-19. The company also collaborates with the National Center for Advancing Translational Sciences (NCATS) on developing emetine hydrochloride for COVID-19 and holds worldwide licensing rights for osanetant, a selective NK3 receptor antagonist, through an agreement with Sanofi. Established in 1991, Acer Therapeutics Inc. is headquartered in Newton, Massachusetts.

Key metrics

Market cap
$0
P/E (TTM)
-0.34
EPS (TTM)
$-1.93
Beta
0.44
Dividend yield
0.00%
Revenue / share
$0.00
50-day avg
$0.82
200-day avg
$1.01
52-week high
$4.56
52-week low
$0.55
CEO
Christopher Schelling

ETFs linked to ACER

Broad-market and Healthcare sector ETFs an investor holding Acer Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how ACER fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze ACER in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Acer Therapeutics?
Acer Therapeutics trades under the ticker ACER on NASDAQ.
Which exchange is ACER listed on?
ACER is listed on NASDAQ.
What sector does Acer Therapeutics operate in?
Acer Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze ACER in a portfolio?
PortView shows ACER's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.